Navigation Links
R&J Public Relations Selected to Promote MAQUET Inc.'s VARIOP Operating Room Suite in North America

BRIDGEWATER, N.J., Dec. 8 /PRNewswire/ -- R&J Public Relations, a leading brand-building public relations firm, announced it has been retained to engage in public relations initiatives to promote MAQUET Inc.'s VARIOP operating room suite in North America. MAQUET is a leading global provider of medical equipment and systems known for high quality, cost-effective state-of-the-art technologies.

MAQUET has been installing VARIOP in hospitals in Europe for more than 25 years, and has currently outfitted nearly 2,000 hospitals in Europe with the product. The company recently completed its first-ever installation of VARIOP in North America, with the completion of a large suite of VARIOP operating rooms at Spartanburg Regional in Spartanburg, S.C.

VARIOP, consisting of prefabricated modules whose framework is made up of profiled floor rails, vertical supports and ceiling rails, can be configured to adapt to both new construction as well as remodeling projects. This allows the system to be easily installed in less time and with less disruption and mess than traditional construction methods.

"Our work for MAQUET will help North America's hospitals lower their long-term costs of outfitting and retrofitting operating rooms, yielding them less disruption and increased revenue," said John Lonsdorf, president of R&J Public Relations. "In today's challenging healthcare finance environment, VARIOP will yield immediate benefits for hospitals."

About MAQUET Inc.

MAQUET, a subsidiary of the Swedish-based Getinge Group, is one of the oldest and largest surgical equipment companies in the world. MAQUET, founded 170 years ago, has set consistently new clinical standards and has driven ICU and OR innovations, growing organically and through acquisitions in the US over the last 10 years. MAQUET is the #1 manufacturer of OR Tables, Surgical Lights and Critical Care Ventilators in the world and is a strong player in the ceiling service units, or booms, market with its new MODUTEC line.

MAQUET - The Gold Standard.

About R&J Public Relations

R&J Public Relations LLC is a leading brand-building public relations firm with expertise in many industries - including the healthcare, consumer electronics and not-for-profit sectors - working with organizations that are driven to become market leaders or defend their market leadership position. Headquartered in Bridgewater, N.J., the firm has a highly successful track record communicating its clients' strengths, allowing them to enhance their market positions and build sustainable brand equity. The company's clients around the U.S. range from divisions of large, multi-national conglomerates to regional market leaders and not-for-profit organizations. For more information on R&J Public Relations, visit

SOURCE R&J Public Relations, LLC
Copyright©2008 PR Newswire.
All rights reserved

Related medicine news :

1. UT public health policy expert says US can learn from Dutch universal healthcare coverage
2. Leading Government and Advocacy Stakeholders Engage in Public Health Dialogue on Improving Disposal of Unused Medications
3. GlaxoSmithKline and The Carter Center Reaffirm Commitment to Global Public Health with Expansion of LF Program
4. ASH Honors Speaker of the House Nancy Pelosi and NHLBI Deputy Director Susan Shurin, MD, for Their Public Service, Leadership, and Commitment to Biomedical Research
5. Health Level Seven and The Health Story Project Announce Publication of Diagnostic Imaging Report Guide at Annual RSNA Meeting : HL7 Clinical Document Architecture (CDA) Implementation Guide Enhances Radiology Reporting
6. Tragedies Underscore Crisis in U.S. Public Mental Health System: National Advocacy Organization Demands Reforms
7. Partnership for Safe Medicines Arms Public Against Counterfeit Drugs
8. Hundreds to Gather for Colorado Public Health Summit
9. International workshop aims to boost public engagement work in developing countries
10. Citizens Republic Bancorp Selects HealthPlus as Sole Provider of Health Insurance for 2009
11. Vivisimo Helps OnMedica Deliver Personalized Search and Extend Social Search to Public-Facing Health Portal
Post Your Comments:
(Date:6/25/2016)... California (PRWEB) , ... June 25, 2016 , ... "With ... fit their specific project," said Christina Austin - CEO of Pixel Film Studios. ... customizable and all within Final Cut Pro X . Simply select a ProHand ...
(Date:6/25/2016)... ... 25, 2016 , ... Dr. Calvin Johnson has dedicated his ... implemented orthobiologic procedures as a method for treating his patients. The procedure is ... to perform the treatment. Orthobiologics are substances that orthopaedic surgeons use to help ...
(Date:6/24/2016)... ... June 24, 2016 , ... A recent article published June 14 ... The article goes on to state that individuals are now more comfortable seeking to ... operations such as calf and cheek reduction. The Los Angeles area medical group, Beverly ...
(Date:6/24/2016)... ... ... Marcy was in a crisis. Her son James, eight, was out of control. Prone to ... , “When something upset him, he couldn’t control his emotions,” remembers Marcy. “If there ... my other children and say he was going to kill them. If we were ...
(Date:6/24/2016)... (PRWEB) , ... June 24, 2016 , ... ... now offering micro-osteoperforation for accelerated orthodontic treatment. Dr. Cheng has extensive experience with ... Damon brackets , AcceleDent, and accelerated osteogenic orthodontics. , Micro-osteoperforation is a ...
Breaking Medicine News(10 mins):
(Date:6/23/2016)... Research and Markets has announced ... Type (Organic Chemical (Sugar, Petrochemical, Glycerin), Inorganic Chemical), Functionality ... - Global Forecast to 2021" report to their ... global pharmaceutical excipients market is projected to reach USD ... in the forecast period 2016 to 2021. ...
(Date:6/23/2016)... -- Roche (SIX: RO, ROG; OTCQX: RHHBY) announced that ... PCT (procalcitonin) assay as a dedicated testing solution for ... clearance, Roche is the first IVD company in the ... risk assessment and management. PCT is a ... in blood can aid clinicians in assessing the risk ...
(Date:6/23/2016)... 2016 Capricor Therapeutics, Inc. ... biotechnology company focused on the discovery, development and ... enrollment in its ongoing randomized HOPE-Duchenne clinical trial ... of its 24-patient target. Capricor expects the trial ... of 2016, and to report top line data ...
Breaking Medicine Technology: